Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
DXM42I
|
||||
Drug Name |
4-Chloro-N-[1-(4-chloro-benzoyl)-5-(2-fluoro-phenyl)-2-oxo-2,3-dihydro-1H-benzo[e][1,4]diazepin-3-yl]-benzamide
|
||||
Synonyms |
CHEMBL70593
|
||||
Indication | Discovery agent | Investigative | [1587926] | ||
Formula |
C29H18Cl2FN3O3
|
||||
Canonical SMILES |
Fc1ccccc1C2=NC(NC(=O)c3ccc(Cl)cc3)C(=O)N(C(=O)c4ccc(Cl)cc4)c5ccccc25
|
||||
InChI |
InChI=1S/C29H18Cl2FN3O3/c30-19-13-9-17(10-14-19)27(36)34-26-29(38)35(28(37)18-11-15-20(31)16-12-18)24-8-4-2-6-22(24)25(33-26)21-5-1-3-7-23(21)32/h1-16,26H,(H,34,36)
|
||||
InChIKey |
FMPRFCINNRGLNV-UHFFFAOYSA-N
|
||||
Target and Pathway | |||||
Target(s) | Gastrin/cholecystokinin type B receptor | Target Info | [1587926] | ||
Cholecystokinin receptor type A | Target Info | [1587926] | |||
PANTHER Pathway | CCKR signaling map ST | ||||
PathWhiz Pathway | Gastric Acid Production | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.